The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF

European Journal of Immunology

Volumn 46, Issue 5, 2016, Pages 1271-1278

  Moretta, Francesca ^a,b   Petronelli, Francesca ^c   Lucarelli, Barbarella ^d   Pitisci, Angela ^d   Bertaina, Alice ^d   Locatelli, Franco ^d,e   Mingari, Maria Cristina ^f,g   Moretta, Lorenzo ^d   Montaldo, Elisa ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b Stroke Center   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

Author keywords

G CSF HSCT ILC ILC development NK cells Plerixafor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; CD34 ANTIGEN; CD56 ANTIGEN; HETEROCYCLIC COMPOUND; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B; PLERIXAFOR;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID CELL; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; BONE MARROW CELL; CELL COUNT; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOPOIESIS; PHENOTYPE; PHYSIOLOGY;

ANTIGENS, CD34; ANTIGENS, CD56; BONE MARROW CELLS; CELL COUNT; FETAL BLOOD; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; LYMPHOPOIESIS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PHENOTYPE;

EID: 84975787035     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201546079     Document Type: Article

References (24)

1. Diefenbach, A., Colonna, M. and Koyasu, S., Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014. 41: 354-365.
2. Cortez, V. S., Robinette, M. L. and Colonna, M., Innate lymphoid cells: new insights into function and development. Curr. Opin. Immunol. 2015. 32: 71-77.
3. Montaldo, E., Juelke, K. and Romagnani, C., Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice. Eur. J. Immunol. 2015.
4. Montaldo, E., Teixeira-Alves, L. G., Glatzer, T., Durek, P., Stervbo, U., Hamann, W., Babic, M. et al., Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells. Immunity 2014. 41: 988-1000.
5. Renoux, V. M., Zriwil, A., Peitzsch, C., Michaelsson, J., Friberg, D., Soneji, S. and Sitnicka, E., Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues. Immunity 2015. 43: 394-407.
6. Locatelli, F., Pende, D., Mingari, M. C., Bertaina, A., Falco, M., Moretta, A. and Moretta, L., Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells. Front. Immunol. 2013. 4: 15.
7. Aversa, F., Terenzi, A., Tabilio, A., Falzetti, F., Carotti, A., Ballanti, S., Felicini, R. et al., Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J. Clin. Oncol. 2005. 23: 3447-3454.
8. Munneke, J. M., Bjorklund, A. T., Mjosberg, J. M., Garming-Legert, K., Bernink, J. H., Blom, B., Huisman, C. et al., Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 2014. 124: 812-821.
9. Vitale, C., Ambrosini, P., Montaldo, E., Ballerini, F., Moretta, L. and Mingari, M. C., IL-1beta-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors. Haematologica 2015. 100: e42-45.
10. Trabanelli, S., Curti, A., Lecciso, M., Salome, B., Riether, C., Ochsenbein, A., Romero, P. and Jandus, C., CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis. Haematologica 2015. 100: e257-260.
11. Doulatov, S., Notta, F., Laurenti, E. and Dick, J. E., Hematopoiesis: a human perspective. Cell Stem Cell 2012. 10: 120-136.
12. Bendall, L. J. and Bradstock, K. F., G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 2014. 25: 355-367.
13. Rutella, S., Filippini, P., Bertaina, V., Li Pira, G., Altomare, L., Ceccarelli, S., Brescia, L. P. et al., Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-alphabeta/CD19-depleted haploidentical stem cell grafts. J. Transl. Med. 2014. 12: 240.
14. De Clercq, E., Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil) and potential of other CXCR4 antagonists as stem cell mobilizers. Pharmacol. Ther. 2010. 128: 509-518.
15. Miller, J. S., Prosper, F. and McCullar, V., Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997. 90: 3098-3105.
16. Glatzer, T., Killig, M., Meisig, J., Ommert, I., Luetke-Eversloh, M., Babic, M., Paclik, D. et al., RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013. 38: 1223-1235.
17. Ni, J., Miller, M., Stojanovic, A., Garbi, N. and Cerwenka, A., Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 2012. 209: 2351-2365.
18. Rutella, S., Pierelli, L., Bonanno, G., Sica, S., Ameglio, F., Capoluongo, E., Mariotti, A. et al., Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 2002. 100: 2562-2571.
19. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S. et al., Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 2013. 13: 145-149.
20. Luevano, M., Madrigal, A. and Saudemont, A., Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy. Cell Mol. Immunol. 2012. 9: 310-320.
21. Vitale, C., Chiossone, L., Morreale, G., Lanino, E., Cottalasso, F., Moretti, S., Dini, G. et al., Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation. Eur. J. Immunol. 2004. 34: 455-460.
22. Della Chiesa, M., Falco, M., Podesta, M., Locatelli, F., Moretta, L., Frassoni, F. and Moretta, A., Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 2012. 119: 399-410.
23. Wang, H., Grzywacz, B., Sukovich, D., McCullar, V., Cao, Q., Lee, A. B., Blazar, B. R. et al., The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood 2007. 110: 1530-1539.
24. Bertaina, A., Merli, P., Rutella, S., Pagliara, D., Bernardo, M. E., Masetti, R., Pende, D. et al., HLA-haploidentical stem cell transplantation after removal of alphabeta+ T and B cells in children with nonmalignant disorders. Blood 2014. 124: 822-826.